These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10467)

  • 1. Histamine H2-receptor antagonists and gastric acid secretion -- a progress report.
    Black JW
    Klin Wochenschr; 1976 Oct; 54(19):911-4. PubMed ID: 10467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H2 receptor antagonists.
    Siepler JK; Campagna KD; Donahue PE; Bombeck CT
    Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
    Domschke W; Domschke S; Demling L
    Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of gastric secretion: current progress.
    Carter DC
    Br J Surg; 1976 Oct; 63(10):788-92. PubMed ID: 11030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine H2-receptor antagonists and gastric acid secretion.
    Pounder RE
    Pharmacol Ther; 1984; 26(2):221-34. PubMed ID: 6152495
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the actions of cimetidine and metiamide on gastric acid secretion in the isolated guinea pig gastric mucosa.
    Sjöstrand SE; Ryberg B; Olbe L
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):139-42. PubMed ID: 13317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cimetidine; new hope for ulcer patients?].
    Festen HP; Lamersen CB; van Tongeren JH
    Ned Tijdschr Geneeskd; 1978 Jun; 122(24):866-70. PubMed ID: 351434
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.
    Daly MJ; Humphray JM; Stables R
    Gut; 1980 May; 21(5):408-12. PubMed ID: 6107261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discussions with the speakers on histamine-H2-receptor antagonists. 21 April 1978, Vienna].
    Acta Med Austriaca Suppl; 1978; 10():1-11. PubMed ID: 32718
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)].
    Hausamen TU; Fritsch WP; Scholten T; Jungblut R; Strohmeyer G
    Dtsch Med Wochenschr; 1977 Nov; 102(47):1709-12. PubMed ID: 21785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metiamide in the Zollinger-Ellison syndrome.
    Blair EL; Grund ER; Miller IT; Redd JD; Sanders DJ; Thompson MH; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1123-30. PubMed ID: 1106187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
    Lamers CB; Festen HP; van Tongeren JH
    Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine H2-receptor antagonists.
    Sewing KF
    Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):221-6. PubMed ID: 7913
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.
    Burland WL; Duncan WA; Hesselbo T; Mills JG; Sharpe PC; Haggie SJ; Wyllie JH
    Br J Clin Pharmacol; 1975 Dec; 2(6):481-6. PubMed ID: 9952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new form of antihistamine--the H2-receptor antagonist.
    Shearman DJ
    Med J Aust; 1976 Jun; 1(26):1005-9. PubMed ID: 10508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of patients with Zollinger-Ellison syndrome with histamine H2 receptor antagonists].
    Lamers CB
    Tijdschr Gastroenterol; 1977; 20(6):385-93. PubMed ID: 614726
    [No Abstract]   [Full Text] [Related]  

  • 18. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM; Clissold SP
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of duodenal ulceration produced by cysteamine or propionitrile: influence of vagotomy, sympathectomy, histamine depletion, H-2 receptor antagonists and hormones.
    Szabo S; Haith LR; Reynolds ES
    Dig Dis Sci; 1979 Jun; 24(6):471-7. PubMed ID: 37058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histamine-H2-receptor antagonists. Physiological and clinical aspects].
    Domschke W; Domschke S
    Fortschr Med; 1976 Jun; 94(18):1082-4. PubMed ID: 964868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.